CCKP

New features, data, types of data and more

🚀New Tool: LinG3D: Visualizing the Spatio-Temporal Dynamics of Clonal Evolution

By |2026-04-15T18:55:26+00:00April 15, 2026|CCKP, Community News, Tools|

Tumors aren't genetically uniform, and which clones survive and why they survive has direct bearing on treatment resistance. LinG3D adds spatial context to lineage tracing. [...]

Comments Off on 🚀New Tool: LinG3D: Visualizing the Spatio-Temporal Dynamics of Clonal Evolution

📈New Dataset: Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer

By |2026-03-11T17:02:50+00:00March 31, 2026|CCKP, Data Features, Resources|

A new single-cell RNA-sequencing dataset provides in-depth profiling of estrogen receptor (ER)-positive primary and metastatic breast cancer tumors from 23 patients, offering insight into [...]

Comments Off on 📈New Dataset: Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer

📈New Dataset: Impact of post-lysis stopping point prior to reverse transcription

By |2026-03-11T17:00:52+00:00March 11, 2026|CCKP, Data Features, Resources|

We’re excited to share the dataset “Impact of Post-Lysis Stopping Point Prior to Reverse Transcription,” generated using the newly developed particle-templated instant partition sequencing [...]

Comments Off on 📈New Dataset: Impact of post-lysis stopping point prior to reverse transcription

🧰CCKP Toolkit Tool Feature: phangorn

By |2026-02-13T17:36:03+00:00February 13, 2026|CCKP, Tools|

phangorn is an R package for phylogenetic reconstruction and analysis. It supports Maximum Likelihood, Maximum Parsimony, distance-based methods, and Hadamard conjugation, enabling researchers to [...]

Comments Off on 🧰CCKP Toolkit Tool Feature: phangorn

📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

By |2026-01-15T21:39:21+00:00January 15, 2026|CCKP, Data Features|

Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]

Comments Off on 📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma
Go to Top